Synonyms: 1-methyl-D-tryptophan | 1MT | D-1MT
Compound class:
Synthetic organic
Comment: Indoximod is being investigated for its inhibitory action towards indoleamine 2,3-dioxygenase 1 (IDO1), a L-tryptophan degrading enzyme.
|
|
References |
1. Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH. (2009)
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol, 41 (3): 467-71. [PMID:18282734] |
2. Fatokun AA, Hunt NH, Ball HJ. (2013)
Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids, 45 (6): 1319-29. [PMID:24105077] |
3. Meininger D, Zalameda L, Liu Y, Stepan LP, Borges L, McCarter JD, Sutherland CL. (2011)
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochim Biophys Acta, 1814 (12): 1947-54. [PMID:21835273] |
4. Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res, 67 (15): 7082-7. [PMID:17671174] |
5. Metz R, Smith C, DuHadaway JB, Chandler P, Baban B, Merlo LM, Pigott E, Keough MP, Rust S, Mellor AL et al.. (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol, 26 (7): 357-67. [PMID:24402311] |